Optical prescription card

• US 20050187792A1
• Filed: 02/10/2005
• Published: 08/25/2005
• Est. Priority Date: 12/06/1999
• Status: Abandoned Application

• Current Assignee: BSI2000, Inc.
• Original Assignee: BSI2000, Inc.
• Inventors: Harper, W. Jack
• Application Number:
  US11/056,828
• Publication Number:
  US 20050187792A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06Q 10/10 Office automation; Time management
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage

Abstract

According to the invention, a method for distributing drug interaction information for pharmacological compounds is disclosed. In one step, a request is received for a pharmacological compound for administration to a party. A list is received that includes a plurality of other pharmacological compounds associated with the party. A listing of possible drug interactions related to at least one of the pharmacological compound or the plurality of other pharmacological compounds is read from an optical card. It is determined if the pharmacological compound is contraindicated from the listing of possible drug interactions. A subset of the listing of possible drug interactions relevant to use of the pharmacological compound with the plurality of other pharmacological compounds is printed.

Claims

1. A method for distributing drug interaction information for pharmacological compounds, the method comprising steps of:

receiving a request for a pharmacological compound for administration to a party;

receiving a list that includes a plurality of other pharmacological compounds associated with the party;

reading from an optical card a listing of possible drug interactions related to at least one of;

the pharmacological compound, or

the plurality of other pharmacological compounds;

determining if the pharmacological compound is contraindicated from the listing of possible drug interactions; and

printing a subset of the listing of possible drug interactions relevant to use of the pharmacological compound with the plurality of other pharmacological compounds.

2. The method for distributing drug interaction information for pharmacological compounds as recited in claim 1, further comprising steps of:

writing the list to the optical card; and

writing the listing to the optical card, wherein the optical card is written with information to uniquely identify the party that the optical card is issued to.

3. The method for distributing drug interaction information for pharmacological compounds as recited in claim 1, wherein the party is selected from a group consisting of a human and an animal.

4. The method for distributing drug interaction information for pharmacological compounds as recited in claim 1, wherein the printing step includes a step of printing to at least one of a display or a printer.

5. The method for distributing drug interaction information for pharmacological compounds as recited in claim 1, wherein the optical card is uniquely associated with the party.

6. The method for distributing drug interaction information for pharmacological compounds as recited in claim 1, further comprising a step of retrieving software instructions from the optical card, wherein at least one of the determining or printing steps is performed, at least in part, by the software instructions.

7. The method for distributing drug interaction information for pharmacological compounds as recited in claim 1, further comprising a step of determining if the listing of possible drug interactions has been superceded by a new listing of possible drug interactions.

8. The method for distributing drug interaction information for pharmacological compounds as recited in claim 1, further comprising a step of writing a new listing of possible drug interactions to the optical card if it is determined that the listing of possible drug interactions is out of date or invalid.

9. The method for distributing drug interaction information for pharmacological compounds as recited in claim 1, further comprising a step of verifying a trust chain associated with the holder of a new listing of possible drug interactions to validate the listing.

10. A computer system adapted to perform the computer-implementable method for distributing drug interaction information for pharmacological compounds of claim 1.

11. A method for distributing drug interaction information for pharmacological compounds, the method comprising steps of:

providing an optical card written with information to uniquely identify a party that the optical card is issued to;

determining the party associated with the optical card; and

writing to the optical card at least one of;

a list including a plurality of pharmacological compounds associated with the party, or

a listing of possible drug interactions for the plurality of pharmacological compounds to the optical card.

12. The method for distributing drug interaction information for pharmacological compounds as recited in claim 11, further comprising steps of:

receiving a request for a new pharmacological compound for administration to the party;

receiving the list including the plurality of other pharmacological compounds associated with the party;

reading from the optical card the listing of possible drug interactions related to the plurality of pharmacological compounds;

determining if the new pharmacological compound is contraindicated from the listing of possible drug interactions; and

printing a subset of the listing of possible drug interactions relevant to use of the new pharmacological compound with the plurality of pharmacological compounds.

13. The method for distributing drug interaction information for pharmacological compounds as recited in claim 11, wherein the party is selected from a group consisting of a human and an animal.

14. The method for distributing drug interaction information for pharmacological compounds as recited in claim 11, wherein the optical card is uniquely associated with the party.

15. The method for distributing drug interaction information for pharmacological compounds as recited in claim 11, further comprising a step of writing software instructions to the optical card, wherein the software can process at least one of the list or the listing.

16. The method for distributing drug interaction information for pharmacological compounds as recited in claim 11, further comprising a step of writing a certificate that can be used in verifying a trust chain associated with listing.

17. An optical prescription card for use in distributing drug interaction information for pharmacological compounds, the optical prescription card comprising:

party information that is unique to a party who is issued the optical prescription card;

data optically written to the optical prescription card, wherein the data includes at least one of;

a list including a plurality of pharmacological compounds associated with the party, or

a listing including possible drug interactions for the plurality of pharmacological compounds.

18. The optical prescription card for use in distributing drug interaction information for pharmacological compounds as recited in claim 17, wherein the party information does not provide any identity or demographic information to unauthorized persons who access the optical prescription card.

19. The optical prescription card for use in distributing drug interaction information for pharmacological compounds as recited in claim 17, wherein the optical prescription card optically stores at least one megabyte of data.

20. The optical prescription card for use in distributing drug interaction information for pharmacological compounds as recited in claim 17, wherein the optical prescription card is uniquely associated with the party.

21. The optical prescription card for use in distributing drug interaction information for pharmacological compounds as recited in claim 17, further comprising software instructions that are used in processing at least one of the list or the listing.

22. The optical prescription card for use in distributing drug interaction information for pharmacological compounds as recited in claim 17, wherein authenticity of at least one of the list or the listing is verifiable.